NatureWise Biotech & Medicals Corporation (4732.TWO)
TWD 20.25
(-0.49%)
TWD 20.25
(-0.49%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 160.14 Million | 228.59 Million | 249.8 Million | 306.91 Million | 307.46 Million | 108.47 Million |
| Cost of Revenue | 83.17 Million | 109.6 Million | 114.9 Million | 135.53 Million | 146.26 Million | 58.2 Million |
| Gross Profit | 76.96 Million | 118.98 Million | 134.89 Million | 171.38 Million | 161.19 Million | 50.27 Million |
| Operating Expenses | 83.94 Million | 92.64 Million | 107.91 Million | 113.46 Million | 128.31 Million | 72.05 Million |
| Selling, General and Administrative Expenses | 49.53 Million | 49.11 Million | 44.31 Million | 51.07 Million | 50.12 Million | 40.37 Million |
| Research and Development Expenses | 23.99 Million | 43.52 Million | 63.59 Million | 62.38 Million | 78.19 Million | 31.67 Million |
| Other Expenses | - | 106 Thousand | 1.71 Million | -870 Thousand | - | - |
| Cost and Expenses | 156.7 Million | 202.24 Million | 222.82 Million | 248.99 Million | 274.58 Million | 130.25 Million |
| Operating Income | 3.43 Million | 26.34 Million | 26.97 Million | 57.92 Million | 32.88 Million | -21.77 Million |
| Interest Expense | 52 Thousand | 40 Thousand | 32 Thousand | 58 Thousand | 60 Thousand | - |
| Income Tax Expense | -196 Thousand | - | -168 Thousand | -5.98 Million | 3.37 Million | -1.14 Million |
| Earnings before Tax | 9.92 Million | 30.02 Million | 30.64 Million | 59.33 Million | 43.06 Million | -15.96 Million |
| Net Income | 10.12 Million | 30.02 Million | 30.8 Million | 65.31 Million | 39.69 Million | -14.81 Million |
| Earnings Per Share Basic | 0.20 | 0.61 | 0.63 | 1.33 | 1.05 | -0.39 |
| Earnings Per Share Diluted | 0.20 | 0.61 | 0.62 | 1.32 | 1.05 | -0.39 |
| Weighted Average Shares Outstanding | 50.6 Million | 49.29 Million | 49.29 Million | 49.29 Million | 37.8 Million | 38.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 49.9 Million | 49.48 Million | 49.33 Million | 49.36 Million | 37.8 Million | 38.22 Million |
| Gross Margin | 0.48 | 0.52 | 0.54 | 0.56 | 0.52 | 0.46 |
| EBIT Margin | 0.09 | 0.16 | 0.15 | 0.23 | 0.14 | -0.13 |
| Profit Margin | 0.06 | 0.13 | 0.12 | 0.21 | 0.13 | -0.14 |
| EBITDA | 13.85 Million | 37.28 Million | 38.26 Million | 69.97 Million | 54.68 Million | -8.01 Million |
| Earnings Before Tax Margin | 0.02 | 0.12 | 0.11 | 0.19 | 0.11 | -0.20 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 65.39 Million | 65.39 Million | 93.78 Million | 160.14 Million | 46.89 Million | 66.36 Million |
| Cost of Revenue | 29.38 Million | 29.38 Million | 47.69 Million | 83.17 Million | 21.23 Million | 35.48 Million |
| Gross Profit | 36.01 Million | 36.01 Million | 46.08 Million | 76.96 Million | 25.65 Million | 30.87 Million |
| Operating Expenses | 33.31 Million | 33.31 Million | 43.51 Million | 73.52 Million | 24.37 Million | 30.01 Million |
| Selling, General and Administrative Expenses | 14.83 Million | 14.83 Million | 26.83 Million | - | 14.51 Million | 22.7 Million |
| Research and Development Expenses | 18.47 Million | 18.47 Million | 16.67 Million | - | 9.85 Million | 7.31 Million |
| Other Expenses | -1.00 | -1.00 | - | 585 Thousand | - | - |
| Cost and Expenses | 62.7 Million | 62.7 Million | 91.2 Million | 156.7 Million | 45.6 Million | 65.5 Million |
| Operating Income | 2.69 Million | 2.69 Million | 2.57 Million | 3.43 Million | 1.28 Million | 861 Thousand |
| Interest Expense | 58 Thousand | - | 28 Thousand | 52 Thousand | - | 24 Thousand |
| Income Tax Expense | 1.24 Million | 1.24 Million | -196 Thousand | -196 Thousand | 98 Thousand | - |
| Earnings before Tax | 4.89 Million | 4.89 Million | 6.53 Million | 9.92 Million | 3.26 Million | 3.39 Million |
| Net Income | 4.51 Million | 4.51 Million | 6.72 Million | 10.12 Million | 3.36 Million | 3.39 Million |
| Earnings Per Share Basic | 0.09 | 0.09 | 0.14 | - | 0.06 | 0.07 |
| Earnings Per Share Diluted | 0.09 | 0.09 | 0.14 | - | 0.07 | 0.07 |
| Weighted Average Shares Outstanding | 50.17 Million | 50.17 Million | 49.2 Million | 49.29 Million | 51.74 Million | 49.29 Million |
| Weighted Average Shares Outstanding (Diluted) | 49.83 Million | 49.83 Million | 49.2 Million | 49.9 Million | 49.87 Million | 49.94 Million |
| Gross Margin | 0.55 | 0.55 | 0.49 | 0.48 | 0.55 | 0.47 |
| EBIT Margin | 0.07 | 0.07 | 0.08 | - | 0.10 | 0.09 |
| Profit Margin | 0.07 | 0.07 | 0.07 | 0.06 | 0.07 | 0.05 |
| EBITDA | 4.29 Million | 4.29 Million | 7.8 Million | - | 4.9 Million | 6.04 Million |
| Earnings Before Tax Margin | 0.04 | 0.04 | 0.03 | 0.02 | 0.03 | 0.01 |
TSE
4584
ENJOY
ETTE
SCFFF
4220